13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569064
Total reported value
$5.5B
$5.5B
89 檔
19.5%
As reported in its official Q1 2026 Form 13F filing, Montanova Capital, LLC's tracked investment portfolio stood at $5.5B with 89 total positions.
Montanova Capital, LLC executed strategic sector rebalancing during Q1 2026, establishing 15 new positions while fully exiting 19 holdings and trimming 16 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 7.42% | -1.46% | +3.03% | |
| 2 | MANE | Veradermics Inc | Stock-Other | 6.72% | +2.65% | — | |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 5.81% | +7.16% | -56.25% | |
| 4 | PVLA | Palvella Therapeutics Inc | Stock-Other | 3.67% | -0.50% | +29.26% | |
| 5 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 3.62% | -3.62% | EXIT | |
| 6 | LEGN | Legend Biotech Corp-adr | Stock-Other | 3.50% | +0.23% | +14.71% | |
| 7 | BNTC | Benitec Biopharma Inc | Stock-Other | 3.14% | -0.31% | — | |
| 8 | CAPR | Capricor Therapeutics Inc | Stock-Other | 2.97% | -1.16% | +113.85% | |
| 9 | ✓ | Immatics NV | Stock-Other | 2.81% | -0.74% | — | |
| 10 | RCUS | Arcus Biosciences Inc | Stock-Other | 2.78% | -0.09% | -3.04% | |
| 11 | EYPT | Eyepoint Inc | Stock-Other | 2.73% | -0.56% | +5.99% | |
| 12 | AVBP | Arrivent Biopharma Inc | Stock-Other | 2.59% | +0.28% | +7.19% | |
| 13 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 2.58% | +0.08% | +10.06% | |
| 14 | NVDA | Nvidia CORP | Stock-Tech | 2.56% | +0.08% | +8.24% | |
| 15 | META | Meta Platforms Inc-class A | Stock-Comm Services | 2.48% | -0.67% | +0.38% | |
| 16 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 2.45% | -2.45% | EXIT | |
| 17 | GE | General Electric | Stock-Industrials | 2.25% | -0.13% | — | |
| 18 | BHVN | Biohaven Ltd. | Stock-Other | 2.22% | +0.58% | — | |
| 19 | SYY | Sysco CORP | Stock-Consumer Staples | 2.11% | +0.05% | +6.95% | |
| 20 | MGM | Mgm Resorts International | Stock-Consumer Disc | 2.04% | -0.01% | +79.59% | |
| 21 | CMPX | Compass Therapeutics Inc | Stock-Other | 1.93% | -1.37% | +0.88% | |
| 22 | HD | Home Depot Inc | Stock-Consumer Disc | 1.86% | -0.40% | -8.00% | |
| 23 | KURA | Kura Oncology Inc | Stock-Other | 1.78% | -0.06% | — | |
| 24 | GLUE | Monte Rosa Therapeutics Inc | Stock-Other | 1.78% | -0.21% | +25.80% | |
| 25 | BAC | Bank Of America CORP | Stock-Financials | 1.61% | -0.79% | -14.65% | |
| 26 | ERAS | Erasca Inc | Stock-Other | 1.42% | -1.42% | EXIT | |
| 27 | COF | Capital One Financial CORP | Stock-Financials | 1.41% | -0.19% | +75.84% | |
| 28 | ✓ | Zura Bio LTD | Stock-Other | 1.38% | -0.36% | +62.87% | |
| 29 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.35% | -0.46% | -37.46% | |
| 30 | AMD | Advanced Micro Devices | Stock-Tech | 1.34% | +1.39% | -33.97% | |
| 31 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 1.29% | -1.04% | — | |
| 32 | VMC | Vulcan Materials Co | Stock-Materials | 1.26% | -0.10% | — | |
| 33 | FERG | Ferguson Enterprises Inc | Stock-Industrials | 1.26% | -0.19% | +33.11% | |
| 34 | APO | Apollo Global Management Inc | Stock-Financials | 1.10% | -0.27% | -28.59% | |
| 35 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 1.06% | -0.97% | — | |
| 36 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 0.97% | -0.16% | — | |
| 37 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.95% | -0.10% | — | |
| 38 | USFD | US Foods Holding CORP | Stock-Consumer Staples | 0.93% | -0.92% | — | |
| 39 | PFGC | Performance Food Group Co | Stock-Consumer Staples | 0.85% | -0.82% | — | |
| 40 | REPL | Replimune Group Inc | Stock-Other | 0.82% | +0.07% | +11614.96% | |
| 41 | MSOS | Advisorshares Pure US Cann | ETF-Other | 0.82% | +0.08% | +4.34% | |
| 42 | AURA | Aura Biosciences Inc | Stock-Other | 0.75% | +0.19% | — | |
| 43 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.70% | -0.21% | -9.60% | |
| 44 | PROK | Prokidney CORP | Stock-Other | 0.56% | -0.10% | — | |
| 45 | LTH | Life Time Group Holdings Inc | Stock-Other | 0.35% | -0.35% | EXIT | |
| 46 | WHWK | Whitehawk Therapeutics Inc | Stock-Other | 0.33% | +0.03% | — | |
| 47 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.31% | -0.25% | — | |
| 48 | WING | Wingstop Inc | Stock-Consumer Disc | 0.24% | -0.24% | EXIT | |
| 49 | MOLN | Molecular Partners AG -adr | Stock-Other | 0.23% | -0.07% | — | |
| 50 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.20% | -0.09% | -64.94% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CAPR | Capricor Therapeutics Inc | +1.9% | +113.85% | Add |
| 2 | PVLA | Palvella Therapeutics Inc | +1.8% | +29.26% | Add |
| 3 | APLSUSD | Apellis Pharmaceuticals Inc | +1.5% | -15.00% | Trim |
| 4 | MGM | Mgm Resorts International | +1.1% | +79.59% | Add |
| 5 | AVBP | Arrivent Biopharma Inc | +0.9% | +7.19% | Add |
| 6 | TSM | Taiwan Semiconductor-sp Adr | +0.9% | +10.06% | Add |
| 7 | 4XC1 | Kalvista Pharmaceuticals Inc | +0.9% | — | Unchanged |
| 8 | REPL | Replimune Group Inc | +0.8% | +11614.96% | Add |
| 9 | ✓ | Zura Bio LTD | +0.8% | +62.87% | Add |
| 10 | GLUE | Monte Rosa Therapeutics Inc | +0.7% | +25.80% | Add |
| 11 | COF | Capital One Financial CORP | +0.6% | +75.84% | Add |
| 12 | LEGN | Legend Biotech Corp-adr | +0.6% | +14.71% | Add |
| 13 | FERG | Ferguson Enterprises Inc | +0.5% | +33.11% | Add |
| 14 | NVDA | Nvidia CORP | +0.5% | +8.24% | Add |
| 15 | SYY | Sysco CORP | +0.5% | +6.95% | Add |
| 16 | ✓ | Immatics NV | +0.4% | — | Unchanged |
| 17 | CMPX | Compass Therapeutics Inc | +0.4% | +0.88% | Add |
| 18 | ERAS | Erasca Inc | +0.3% | -76.31% | Trim |
| 19 | ARQT | Arcutis Biotherapeutics Inc | +0.3% | +3.03% | Add |
| 20 | GE | General Electric | +0.3% | — | Unchanged |
| 21 | CTNM | Contineum Therapeutics Inc-a | +0.3% | — | Unchanged |
| 22 | AURA | Aura Biosciences Inc | +0.3% | — | Unchanged |
| 23 | RCUS | Arcus Biosciences Inc | +0.3% | -3.04% | Trim |
| 24 | META | Meta Platforms Inc-class A | +0.2% | +0.38% | Add |
| 25 | HD | Home Depot Inc | +0.2% | -8.00% | Trim |
| 26 | WHWK | Whitehawk Therapeutics Inc | +0.2% | — | Unchanged |
| 27 | MDT | Medtronic plc | +0.1% | +188.35% | Add |
| 28 | ISRG | Intuitive Surgical Inc | +0.1% | +117.31% | Add |
| 29 | 2KZ0 | Kezar Life Sciences Inc | +0.1% | — | Unchanged |
| 30 | ABT | Abbott Laboratories | +0.1% | +31.16% | Add |
| 31 | MOLN | Molecular Partners AG -adr | 0% | — | Unchanged |
| 32 | ABEO | Abeona Therapeutics Inc | 0% | — | Unchanged |
| 33 | IFRX | InflaRx N.V. | 0% | — | Unchanged |
| 34 | EW | Edwards Lifesciences CORP | 0% | +68.47% | Add |
| 35 | TMO | Thermo Fisher Scientific Inc | 0% | — | Unchanged |
| 36 | COR | Cencora Inc | 0% | — | Unchanged |
| 37 | SYK | Stryker CORP | 0% | — | Unchanged |
| 38 | DXCM | Dexcom Inc | 0% | — | Unchanged |
| 39 | MDLN | Medline Inc-cl A | 0% | — | Unchanged |
| 40 | MCK | Mckesson CORP | 0% | — | Unchanged |
| 41 | HCA | Hca Healthcare Inc | 0% | — | Unchanged |
| 42 | IQV | Iqvia Holdings Inc | — | — | Unchanged |
| 43 | NTRA | Natera Inc | — | — | Unchanged |
| 44 | MTD | Mettler-toledo International | — | — | Unchanged |
| 45 | WAT | Waters CORP | — | +2.38% | Add |
| 46 | VRDN | Viridian Therapeutics Inc | — | — | Unchanged |
| 47 | A | Agilent Technologies Inc | — | — | Unchanged |
| 48 | VLTO | Veralto CORP | — | — | Unchanged |
| 49 | STE | STERIS plc | — | — | Unchanged |
| 50 | IONS | Ionis Pharmaceuticals Inc | — | — | Unchanged |
According to official SEC Form 13F filings, Montanova Capital, LLC reported a total U.S. public equity portfolio value of $5.5B across 89 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ARQT, MANE, SPY) accounted for 19.5% of total reported equity market value during Q1 2026.
Top New Position Initiated
MANE
市值: $263.3M
Top Position Liquidated / Trimmed
ARKG
前期市值: $241.7M
During Q1 2026, Montanova Capital, LLC's top holdings by market value included ARQT (7.4%)、MANE (6.7%)、SPY (5.8%). The largest single position, ARQT, represented 7.4% of total portfolio value.
In Q1 2026, Montanova Capital, LLC made 73 total portfolio adjustments, initiating 15 new buys, adding to 23 positions, trimming 16 holdings, and fully liquidating 19 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.